Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19

Title
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19
Authors
Keywords
Nrf2, PB125, Carnosic acid, SARS-CoV-2, Coronavirus, COVID-19, Cytokines, Interferon, Endothelium
Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 175, Issue -, Pages 56-64
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.freeradbiomed.2021.05.033

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started